Co Diagnostics Revenue vs. Operating Margin
| CODX Stock | USD 1.01 0.05 4.72% |
Total Revenue | First Reported 2015-12-31 | Previous Quarter 161.1 K | Current Value 641.1 K | Quarterly Volatility 10.1 M |
For Co Diagnostics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Co Diagnostics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Co Diagnostics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Co Diagnostics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Co Diagnostics over time as well as its relative position and ranking within its peers.
CODX |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Co Diagnostics. If investors know CODX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Co Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.308 | Earnings Share (1.38) | Revenue Per Share 0.244 | Quarterly Revenue Growth (0.74) | Return On Assets (0.28) |
The market value of Co Diagnostics is measured differently than its book value, which is the value of CODX that is recorded on the company's balance sheet. Investors also form their own opinion of Co Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Co Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Co Diagnostics' market value can be influenced by many factors that don't directly affect Co Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Co Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Co Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Co Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Co Diagnostics Operating Margin vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Co Diagnostics's current stock value. Our valuation model uses many indicators to compare Co Diagnostics value to that of its competitors to determine the firm's financial worth. Co Diagnostics is rated below average in revenue category among its peers. It is rated below average in operating margin category among its peers . At this time, Co Diagnostics' Total Revenue is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Co Diagnostics' earnings, one of the primary drivers of an investment's value.CODX Revenue vs. Competition
Co Diagnostics is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 675.36 Million. Co Diagnostics claims roughly 6.81 Million in revenue contributing just under 2% to equities under Health Care industry.
CODX Operating Margin vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Co Diagnostics |
| = | 6.81 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Co Diagnostics |
| = | (15.96) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CODX Operating Margin Comparison
Co Diagnostics is currently under evaluation in operating margin category among its peers.
Co Diagnostics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Co Diagnostics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Co Diagnostics will eventually generate negative long term returns. The profitability progress is the general direction of Co Diagnostics' change in net profit over the period of time. It can combine multiple indicators of Co Diagnostics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 146.7 K | 154 K | |
| Operating Income | -42.7 M | -40.6 M | |
| Net Loss | -42.6 M | -40.4 M | |
| Income Before Tax | -38.1 M | -36.2 M | |
| Total Other Income Expense Net | 4.6 M | 4.8 M | |
| Net Loss | -16.4 M | -15.6 M | |
| Net Loss | -35.3 M | -33.6 M | |
| Income Tax Expense | -2.8 M | -2.6 M | |
| Interest Income | 1 M | 1.1 M | |
| Net Interest Income | 1 M | 1.1 M | |
| Non Operating Income Net Other | 9.4 M | 9.8 M | |
| Change To Netincome | 24.2 M | 25.4 M | |
| Net Loss | (1.20) | (1.14) | |
| Income Quality | 0.62 | 0.69 | |
| Net Income Per E B T | 0.93 | 0.98 |
CODX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Co Diagnostics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Co Diagnostics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Co Diagnostics' important profitability drivers and their relationship over time.
Use Co Diagnostics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Co Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Co Diagnostics will appreciate offsetting losses from the drop in the long position's value.Co Diagnostics Pair Trading
Co Diagnostics Pair Trading Analysis
The ability to find closely correlated positions to Co Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Co Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Co Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Co Diagnostics to buy it.
The correlation of Co Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Co Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Co Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Co Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Co Diagnostics position
In addition to having Co Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.